Franklin Resources’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$485K	Hold	108,399	–	–	﹤0.01%	2471
2025 Q4	$596K	Hold	108,399	–	–	﹤0.01%	2325
2025 Q3	$354K	Hold	108,399	–	–	﹤0.01%	2589
2025 Q2	$250K	Sell	108,399 -7,839	-7%	-$17K	﹤0.01%	2642
2025 Q1	$162K	Buy	+116,238	New	+$194K	﹤0.01%	2740
2024 Q4	–	Sell	-100,795	Closed	-$201K	–	3027
2024 Q3	$201K	Buy	+100,795	New	+$221K	﹤0.01%	2637
2023 Q4	–	Sell	-810,840	Closed	-$2.56M	–	2723
2023 Q3	$2.56M	Hold	810,840	–	–	﹤0.01%	1303
2023 Q2	$536K	Hold	810,840	–	–	﹤0.01%	1940
2023 Q1	$647K	Sell	810,840 -229	-0%	-$296	﹤0.01%	1615
2022 Q4	$1.83M	Hold	811,069	–	–	﹤0.01%	1388
2022 Q3	$1.56M	Hold	811,069	–	–	﹤0.01%	1417
2022 Q2	$3.02M	Sell	811,069 -489,599	-38%	-$1.94M	﹤0.01%	1244
2022 Q1	$8.48M	Sell	1,300,668 -7,865	-0.6%	-$58.8K	﹤0.01%	1055
2021 Q4	$15.2M	Sell	1,308,533 -1,677	-0.1%	-$25.3K	0.01%	959
2021 Q3	$24.4M	Buy	1,310,210 +4,364	+0.3%	+$83K	0.01%	847
2021 Q2	$27.7M	Buy	1,305,846 +186,677	+17%	+$4.3M	0.01%	792
2021 Q1	$22.7M	Buy	1,119,169 +319,640	+40%	+$8.65M	0.01%	809
2020 Q4	$21.2M	Sell	799,529 -991	-0.1%	-$21.3K	0.01%	804
2020 Q3	$17.9M	Buy	+800,520	New	+$18.8M	0.01%	798